GEHC insider trading

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Company website: www.gehealthcare.com

GEHC insider activity at a glance

Latest GEHC Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading GEHC

13F funds holding GEHC

Politicians who have traded GEHC

Frequently asked

How many insider trades does FilingIQ track for GEHC?

FilingIQ tracks 308 Form 4 insider transactions for GEHC (GE HealthCare Technologies Inc.), covering filings from Jan 3, 2023 onwards. 38 of those were filed in the last 90 days.

Are GEHC insiders net buyers or net sellers?

Across the full Form 4 history for GEHC, 9 transactions (3%) were open-market purchases and 13 (4%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GEHC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GEHC in?

GE HealthCare Technologies Inc. (GEHC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $27.90B.